These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 27615012)

  • 1. Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort.
    Knupp KG; Leister E; Coryell J; Nickels KC; Ryan N; Juarez-Colunga E; Gaillard WD; Mytinger JR; Berg AT; Millichap J; Nordli DR; Joshi S; Shellhaas RA; Loddenkemper T; Dlugos D; Wirrell E; Sullivan J; Hartman AL; Kossoff EH; Grinspan ZM; Hamikawa L;
    Epilepsia; 2016 Nov; 57(11):1834-1842. PubMed ID: 27615012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to treatment in a prospective national infantile spasms cohort.
    Knupp KG; Coryell J; Nickels KC; Ryan N; Leister E; Loddenkemper T; Grinspan Z; Hartman AL; Kossoff EH; Gaillard WD; Mytinger JR; Joshi S; Shellhaas RA; Sullivan J; Dlugos D; Hamikawa L; Berg AT; Millichap J; Nordli DR; Wirrell E;
    Ann Neurol; 2016 Mar; 79(3):475-84. PubMed ID: 26704170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms.
    Yuskaitis CJ; Mytinger JR; Baumer FM; Zhang B; Liu S; Samanta D; Hussain SA; Yozawitz EG; Keator CG; Joshi C; Singh RK; Bhatia S; Bhalla S; Shellhaas R; Harini C;
    Neurology; 2022 Nov; 99(22):e2494-e2503. PubMed ID: 36038267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium.
    Demarest ST; Shellhaas RA; Gaillard WD; Keator C; Nickels KC; Hussain SA; Loddenkemper T; Patel AD; Saneto RP; Wirrell E; Sánchez Fernández I; Chu CJ; Grinspan Z; Wusthoff CJ; Joshi S; Mohamed IS; Stafstrom CE; Stack CV; Yozawitz E; Bluvstein JS; Singh RK; Knupp KG;
    Epilepsia; 2017 Dec; 58(12):2098-2103. PubMed ID: 29105055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S; Gulab S; Ishaque S; Saleem T
    BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epileptic spasms in CDKL5 deficiency disorder: Delayed treatment and poor response to first-line therapies.
    Olson HE; Demarest S; Pestana-Knight E; Moosa AN; Zhang X; Pérez-Pérez JR; Weisenberg J; O'Connor Prange E; Marsh ED; Rajaraman RR; Suter B; Katyayan A; Haviland I; Daniels C; Zhang B; Greene C; DeLeo M; Swanson L; Love-Nichols J; Benke T; Harini C; Poduri A
    Epilepsia; 2023 Jul; 64(7):1821-1832. PubMed ID: 37114835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prioritizing Hormone Therapy Over Vigabatrin as the First Treatment for Infantile Spasms: A Quality Improvement Initiative.
    Mytinger JR; Parker W; Rust SW; Ahrens SM; Albert DVF; Beatty CW; Chrisman J; Clark DJ; Debs A; Denney D; Karn M; Herbst J; Ostendorf AP; Taylor MC; Twanow JDE; Vidaurre J; Patel AD
    Neurology; 2022 Nov; 99(19):e2171-e2180. PubMed ID: 36038276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
    Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
    Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA; Lam WM; Manasco KB
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study.
    Vigevano F; Cilio MR
    Epilepsia; 1997 Dec; 38(12):1270-4. PubMed ID: 9578521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
    Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
    Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
    Jones K; Snead OC; Boyd J; Go C
    J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy.
    Zafeiriou DI; Kontopoulos EE; Tsikoulas IG
    Brain Dev; 1996; 18(6):450-2. PubMed ID: 8980841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal trends in the cost and use of first-line treatments for infantile epileptic spasms syndrome.
    Sánchez Fernández I; Amengual-Gual M; Barcia Aguilar C; Romeu A; Sheikh T; Torres A; Chao J; Jonas R; Gaínza-Lein M; Harini C; Douglass L
    Epilepsia; 2023 Mar; 64(3):630-640. PubMed ID: 36600453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication selection, health services outcomes, and cost trajectories for Medicaid beneficiaries with infantile spasms.
    Min JY; Knupp KG; Patel AD; Shellhaas RA; Zhang M; Grinspan ZM
    Epilepsy Res; 2021 Oct; 176():106733. PubMed ID: 34333373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical treatment of patients with infantile spasms.
    Mikati MA; Lepejian GA; Holmes GL
    Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.